Subacute cutaneous lupus erythematosus with positive anti‐Ro antibodies following palbociclib and letrozole treatment: A case report and literature review-Reference-Cited by-同舟云学术

Subacute cutaneous lupus erythematosus with positive anti‐Ro antibodies following palbociclib and letrozole treatment: A case report and literature review

Published:2020-03-13 Issue:7 Volume:47 Page:654-658
ISSN:0303-6987
Container-title:Journal of Cutaneous Pathology
language:en
Short-container-title:J Cutan Pathol

Author:

Russell‐Goldman Eleanor¹,Nazarian Rosalynn M.²^ORCID

Affiliation:

1. Department of PathologyBrigham and Women's Hospital Boston Massachusetts USA

2. Department of PathologyMassachusetts General Hospital Boston Massachusetts USA

Publisher

Wiley

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cup.13673

Reference19 articles.

1. Subacute Cutaneous Lupus Erythematosus Associated with Hydrochlorothiazide Therapy

2. A systematic review of drug-induced subacute cutaneous lupus erythematosus

3. Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden

4. Targeted Cancer Therapy: The Next Generation of Cancer Treatment

5. Specific inhibition of cyclin‐dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts;Fry DW;Mol Cancer Ther,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palbociclib-induced subacute cutaneous lupus erythematosus;Annales de Dermatologie et de Vénéréologie;2024-06

2. Abemaciclib-Associated Skin, Hair, and Nail Toxicities: A Case Report;Cureus;2024-04-05

3. Dermatologic toxicities to inhibitors of cyclin-dependent kinases CDK 4 and 6: An updated review for clinical practice;Annales de Dermatologie et de Vénéréologie;2023-09

4. The Therapeutic Potential of CDK4/6 Inhibitors, Novel Cancer Drugs, in Kidney Diseases;International Journal of Molecular Sciences;2023-08-31

5. Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer;Journal of Oncology Pharmacy Practice;2023-07-16